Clinical Trials Directory

Trials / Completed

CompletedNCT04155632

Neurocircuit Strategy to Decrease Cocaine Cue Reactivity

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The overarching goal of this project is to examine the effect of combining theta burst stimulation (TBS) and N-acetylcysteine (NAC) on cocaine craving and brain response to cocaine-related images.

Conditions

Interventions

TypeNameDescription
DRUGN-acetylcysteineN-acetylcysteine (NAC) is a medication that is used to treat paracetamol (acetaminophen) overdose, and to loosen thick mucus in individuals with cystic fibrosis or chronic obstructive pulmonary disease. It has a long-established safety record in adults and children, with FDA approval since 1963. The side effects most commonly noted in people who take NAC by mouth include diarrhea, nausea, vomiting, and headache. These side effects are usually mild and go away even with continued use of NAC by mouth. There is also a risk of a skin reaction, such as flushing, itching, or rash. A meta-analysis of studies evaluating long-term oral treatment with NAC for prevention of chronic bronchitis found that NAC was well tolerated, with generally mild, most commonly gastrointestinal adverse effects that did not require treatment interruption.
DEVICETheta-burst stimulation (TBS)Theta-burst stimulation (TBS), a form of repetitive transcranial magnetic stimulation (rTMS), affects brain areas stimulated directly underneath the scalp and brain areas that are functionally connected.

Timeline

Start date
2020-12-18
Primary completion
2023-03-09
Completion
2023-03-09
First posted
2019-11-07
Last updated
2025-09-24
Results posted
2025-09-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04155632. Inclusion in this directory is not an endorsement.